Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases. - Wikidata - awgldk - TriplyDB

Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases.

Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases.

http://www.wikidata.org/entity/Q38427228

about

Language performance in Alzheimer's disease and mild cognitive impairment: A comparative review Thalamic pathology and memory loss in early Alzheimer's disease: moving the focus from the medial temporal lobe to Papez circuit The ubiquitin-proteasome system in Alzheimer's disease Auditory spatial processing in Alzheimer's disease.Capturing multidimensionality in stroke aphasia: mapping principal behavioural components to neural structures Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models Delay and probability discounting as candidate markers for dementia: an initial investigation Establishing robust cognitive dimensions for characterization and differentiation of patients with Alzheimer's disease, mild cognitive impairment, frontotemporal dementia and depression.Anomia as a marker of distinct semantic memory impairments in Alzheimer's disease and semantic dementia.Alzheimer's disease genes are associated with measures of cognitive ageing in the lothian birth cohorts of 1921 and 1936 Mild cognitive impairment in different functional domains and incident Alzheimer's disease Neuropsychological characteristics of mild cognitive impairment subgroups.Diagnosis and treatment of dementia: 2. Diagnosis.Verbal fluency predicts mortality in Alzheimer disease.Is mild cognitive impairment a valid target of therapy.Altered Gray Matter Structural Covariance Networks in Early Stages of Alzheimer's Disease Clinical features of mild cognitive impairment differ in the research and tertiary clinic settings Objective metamemory testing captures awareness of deficit in Alzheimer's disease.Using principal component analysis to capture individual differences within a unified neuropsychological model of chronic post-stroke aphasia: Revealing the unique neural correlates of speech fluency, phonology and semantics.Overview and ways forward for future research.Repetitive and stereotypic phenomena and dementia.The Cambridge Semantic Memory Test Battery: detection of semantic deficits in semantic dementia and Alzheimer's disease.Linguistic Features Identify Alzheimer's Disease in Narrative Speech.Improvement of episodic memory in persons with mild cognitive impairment and healthy older adults: evidence from a cognitive intervention program.Non-literal language deficits in mild cognitive impairment.A direct comparison of errorless and errorful therapy for object name relearning in Alzheimer's disease.Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease.Finite case series or infinite single-case studies? Comments on "Case series investigations in cognitive neuropsychology" by Schwartz and Dell (2010).Higher serum insulin-like growth factor-1 is associated with better cognitive performance in persons with mild cognitive impairment.Cognitive rehabilitation in a visual variant of Alzheimer's disease.Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aβ oligomers accumulation.Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia.Triangulation of language-cognitive impairments, naming errors and their neural bases post-stroke.Analysis of brief language tests in the detection of cognitive decline and dementia.Vestibular Loss Predicts Poorer Spatial Cognition in Patients with Alzheimer's Disease.Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging.Assessment of cognitive function in patients with stress-related exhaustion using the Cognitive Assessment Battery (CAB).Neurogranin as a predictor of memory and executive function decline in MCI patients.Predicting the outcome of anomia therapy for people with aphasia post CVA: both language and cognitive status are key predictors.

P2860

Q22248003-1F3255FF-7B7F-4845-BCB1-01525C2FEF20 Q26748827-CD5B9F2C-322D-4F30-BE9E-C23A427946E3 Q28268311-34A46032-D39D-49E2-807B-93CB7F017A97 Q30418044-2D657915-7511-4B37-8C73-1E4D56099228 Q30425468-148E73E9-FD13-4FDC-BCA4-02E2E6CE6AFC Q33937968-07FD14EA-C8FF-4E52-8883-A040377D15EC Q34418781-DC980D58-1D93-4A7D-B2D7-4EDBF95203F4 Q34683626-05BFBE1C-E944-4F4D-948E-B3BF78971E26 Q34692886-67AF01FF-048C-41CC-AE12-E4134A5120F2 Q35074660-65F8B579-251C-4DC6-83FE-E5C9BFC13EDE Q35094369-9B2B88FD-63B0-4361-A92E-98A2C6CB09A3 Q35485098-66320AB0-0790-46AE-A34A-D9699AFF0C53 Q36142452-4005EA15-0C94-4666-BD2A-7A337FA8C799 Q36496530-DF040BEA-488F-4D0F-BF9A-9C14ED0B1298 Q36740278-E6E9D74C-0F5E-4E16-8B0D-40C050C986E1 Q36806657-E4F840AA-C8BD-4491-A9AB-8BB0007A64FD Q36908516-0B6554DE-F74B-42BD-8636-53A1F8370D29 Q37154394-7937D1AF-BE26-4405-B1F5-F1B1BC9E32C5 Q37178249-DABB789B-859B-4498-A09F-D709C1E29D38 Q37604807-F3ED73F3-4F5D-44D9-98DE-FF30D2A7B090 Q37989236-0A5414C6-CF35-4F90-81F6-5BAF56D273EF Q38091406-E725F884-389D-4ED5-A273-BA1D8B454E92 Q38374227-E4B65DD7-57E8-4F6C-AE15-96DD2292D9CD Q38401648-5485AF5D-9B6E-4C46-80AB-C4A501B9460A Q38402920-871581D2-4351-43C5-A454-9201220FAAEF Q38419345-6429EC39-FF23-4813-9A14-571721224934 Q38475339-FD8B44C7-48DE-464E-9C90-FF93868086E7 Q38490466-ABCB53B9-BB41-481E-9B7F-C33AA5F5A993 Q39594130-9D0044ED-62F8-45E4-BC61-F4721A5DF010 Q41012203-5B3201A8-D1B7-4E16-80A6-0AA319D3ED19 Q41662370-928D58D5-C40D-4695-BD90-E9C486BCB9C5 Q41688795-080568A3-5177-41F4-B25D-364D71A9D8A8 Q43480416-030C3665-D786-4E78-A5EB-2DE57F62E5CA Q44952679-E6049163-1AF1-434E-917A-7B402AFAAE54 Q46201889-9E06881C-4D3F-4944-A6B9-5059CC7D6AC9 Q47563013-F06DCCF0-859D-4FFE-BDA5-9364878C8F8E Q47574138-970AC186-F0A5-43E7-A07E-B980555736B0 Q47718504-B90CB014-7680-41B3-8629-E98B62B95216 Q50048402-DB4CDAEA-4C5D-45B5-BD9D-D5B6E022A7E6 Q50149099-426494F8-6AC8-4C6F-969A-45720B53C6F0

P2860

Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases.

http://www.wikidata.org/entity/Q38427228

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Homogeneity and heterogeneity ...... ongitudinal study of 55 cases.

@en

type

label

Homogeneity and heterogeneity ...... ongitudinal study of 55 cases.

@en

prefLabel

Homogeneity and heterogeneity ...... ongitudinal study of 55 cases.

@en

P1433

Q38427228-3EF7A34B-B422-4E34-A20C-B8C0A86C28A9

P1476

Q38427228-EAEED01E-8656-4C92-8F85-23997485376D

P2093

Q38427228-3BDACB5B-7A76-47D2-A655-5A3683462247

Q38427228-6413B5C6-C1B4-42FC-9BDD-EEF21E12E770

Q38427228-83AB8862-1291-4074-80AE-43C51346C56B

Q38427228-91173A9E-7667-4112-AE89-46320A444A39

P2860

Q38427228-003F9FC8-BD76-4EBD-AAD4-6F86B2E074E9

Q38427228-0972227F-AC8F-45F7-A730-8137F75FCE1A

Q38427228-14A782B0-AC9C-41C5-84A2-2227A00A6231

Q38427228-171C43F3-1AEF-4AE1-B61A-6733BBF92F12

Q38427228-1987B35A-19E9-4BC7-A46E-C7C674CD6CE2

Q38427228-1ABC1CBB-9B28-4F14-AB17-4D6596C313DC

Q38427228-23CB208E-D74B-4387-B9E0-3368A80CF85A

Q38427228-24515C0E-F6F6-473F-9372-05EAC814391B

Q38427228-25AEDC63-415D-4C72-BC66-4A62C604FA49

Q38427228-2D9EAD9D-8561-4DE8-AEA5-99897E73C451

P304

Q38427228-0A72744B-7D15-4212-BBAC-2130053F0CBD

P31

Q38427228-09434B79-BFAD-4241-B16A-D832F12D65DF

P356

Q38427228-5B08D5EC-EA30-4D8B-B171-3C5B46FE139E

P407

Q38427228-1C5CE84B-E2FD-4EF4-A84A-BEEB8A714D81

P433

Q38427228-1F3446A9-1AD0-4AF3-8AED-28798489B578

P478

Q38427228-F916C97B-60A6-40B4-AA5F-B5539E59B5B4

P50

Q38427228-4E0CD7D8-E42F-406C-9A17-D0CD420EFFDB

P577

Q38427228-FE1296E1-C5A1-4DE4-9EE9-7757204C322C

P5875

Q38427228-43A9CC6F-7BCF-4129-B694-08ABDCF7B849

P698

Q38427228-D029F6A9-049E-4EFA-9AA3-5B3D3BC0B525

P356

P1433

P1476

Homogeneity and heterogeneity ...... ongitudinal study of 55 cases.

@en

P2093

John R Hodges

http://www.w3.org/2001/XMLSchema#string

Karalyn Patterson

http://www.w3.org/2001/XMLSchema#string

Kate Dawson

http://www.w3.org/2001/XMLSchema#string

Naida Graham

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Mild cognitive impairment: clinical characterization and outcome

Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease

Neuropsychological subgroups of patients with Alzheimer's disease: an examination of the first 10 years of CERAD data.

Semantic dementia: relevance to connectionist models of long-term memory.

Frontotemporal dementia (Pick's disease): clinical features and assessment.

Attention and executive deficits in Alzheimer's disease. A critical review.

Neuropsychological syndromes in presenile dementia due to cerebral atrophy.

P304

2350-2362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWG236

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 11

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P50

Matthew A Lambon Ralph

P577

2003-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10649175

http://www.w3.org/2001/XMLSchema#string

P698

12876147

http://www.w3.org/2001/XMLSchema#string